Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2007 2
2008 2
2009 3
2010 3
2011 1
2012 4
2013 4
2014 2
2016 4
2017 2
2018 4
2019 6
2020 6
2021 5
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
A gene expression-based classifier for HER2-low breast cancer.
Di Cosimo S, Pizzamiglio S, Ciniselli CM, Duroni V, Cappelletti V, De Cecco L, De Marco C, Silvestri M, De Santis MC, Vingiani A, Paolini B, Orlandi R, Iorio MV, Pruneri G, Verderio P. Di Cosimo S, et al. Sci Rep. 2024 Feb 1;14(1):2628. doi: 10.1038/s41598-024-52148-7. Sci Rep. 2024. PMID: 38297001 Free PMC article.
Genetic Loss of miR-205 Causes Increased Mammary Gland Development.
Cataldo A, Cheung DG, Hagan JP, Fassan M, Sandhu-Deol S, Croce CM, Di Leva G, Iorio MV. Cataldo A, et al. Among authors: iorio mv. Noncoding RNA. 2023 Dec 31;10(1):4. doi: 10.3390/ncrna10010004. Noncoding RNA. 2023. PMID: 38250804 Free PMC article.
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO.
Di Cosimo S, Ciniselli CM, Pizzamiglio S, Cappelletti V, Silvestri M, El-Abed S, Izquierdo M, Bajji M, Nuciforo P, Huober J, Cameron D, Chia S, Gomez HL, Iorio MV, Vingiani A, Pruneri G, Verderio P. Di Cosimo S, et al. Among authors: iorio mv. Front Oncol. 2023 Jan 31;12:1028825. doi: 10.3389/fonc.2022.1028825. eCollection 2022. Front Oncol. 2023. PMID: 36798690 Free PMC article.
Worldwide SARS-CoV-2 haplotype distribution in early pandemic.
Cairo A, Iorio MV, Spena S, Tagliabue E, Peyvandi F. Cairo A, et al. Among authors: iorio mv. PLoS One. 2022 Feb 16;17(2):e0263705. doi: 10.1371/journal.pone.0263705. eCollection 2022. PLoS One. 2022. PMID: 35171928 Free PMC article.
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.
Pizzamiglio S, Cosentino G, Ciniselli CM, De Cecco L, Cataldo A, Plantamura I, Triulzi T, El-Abed S, Wang Y, Bajji M, Nuciforo P, Huober J, Ellard SL, Rimm DL, Gombos A, Daidone MG, Verderio P, Tagliabue E, Di Cosimo S, Iorio MV. Pizzamiglio S, et al. Among authors: iorio mv. Cancer Med. 2022 Jan;11(2):332-339. doi: 10.1002/cam4.4449. Epub 2021 Dec 17. Cancer Med. 2022. PMID: 34921525 Free PMC article. Clinical Trial.
Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended.
Giussani M, Ciniselli CM, De Cecco L, Lecchi M, Dugo M, Gargiuli C, Mariancini A, Mancinelli E, Cosentino G, Veneroni S, Paolini B, Orlandi R, Gennaro M, Iorio MV, Depretto C, Ferranti C, Sozzi G, Sensi M, Colombo MP, Scaperrotta G, Tagliabue E, Verderio P. Giussani M, et al. Cancers (Basel). 2021 Aug 10;13(16):4028. doi: 10.3390/cancers13164028. Cancers (Basel). 2021. PMID: 34439180 Free PMC article.
A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosis.
Lecchi M, Verderio P, Cappelletti V, De Santis F, Paolini B, Monica M, Sangaletti S, Pupa SM, Iorio MV, Bianchi G, Gennaro M, Fucà G, De Braud F, Tagliabue E, Di Nicola M. Lecchi M, et al. Mol Oncol. 2021 May;15(5):1345-1357. doi: 10.1002/1878-0261.12912. Epub 2021 Feb 19. Mol Oncol. 2021. PMID: 33523584 Free PMC article.
56 results